Sterile Water Injection
Product Images NDC 63323-185

18 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Sterile Water (NDC 63323-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Glu02 0004 01)

Figure (Glu02 0004 01)
Chemical structure diagram displaying the linear amino acid sequence of the peptide hormone glucagon. The sequence includes 29 residues, starting with Histidine (His) and ending with Threonine (Thr), labeled with position numbers from 1 to 29.*
FDA Label Image

Figure (Glu02 0004 02)

Figure (Glu02 0004 02)
A line graph illustrating blood glucose concentration over time in minutes. The x-axis represents time from -15 to 30 minutes, and the y-axis shows blood glucose concentration in mg/dL, ranging from 0 to 160. Data points with error bars indicate measured blood glucose levels, showing an increase starting around time zero and continuing upward past 15 minutes.*
FDA Label Image

Figure A (Glu02 0004 03)

Figure A (Glu02 0004 03)
Illustration of a Glucagon 1 mL/mL kit components, including vial containing powder with rubber stopper and orange plastic cap, needle cover, attached needle, backstop, prefilled syringe containing sterile water, and plunger, showing preparation elements for drug reconstitution.*
FDA Label Image

Figure B (Glu02 0004 04)

Figure B (Glu02 0004 04)
An instructional illustration showing two hands preparing a vial or ampule, depicting the step of breaking or opening the top of a glass container typically used for medicines like glucagon kits.*
FDA Label Image

Figure C (Glu02 0004 05)

Figure C (Glu02 0004 05)
Instructional illustration showing two hands assembling a syringe and vial. An arrow labeled "Pull Straight Off" points to the vial cap, indicating removal direction. This guides the proper method for detaching the vial cap before use.*
FDA Label Image

Figure D (Glu02 0004 06)

Figure D (Glu02 0004 06)
An instructional diagram showing two hands, one holding a vial cap and the other removing it from the vial. The image includes an arrow indicating the direction of removal, illustrating how to open the vial before use in the Glucagon 1 mL/mL kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure E (Glu02 0004 07)

Figure E (Glu02 0004 07)
An instructional diagram showing two hands manipulating a vial and a syringe, with an arrow indicating an action such as pulling off a cap or preparing the vial for use. The image is related to the preparation or handling of the Glucagon 1 mL/mL kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure F (Glu02 0004 08)

Figure F (Glu02 0004 08)
An instructional illustration depicting a hand gripping a device or vial, with arrows indicating a shaking or mixing motion. This likely demonstrates how to prepare the Glucagon 1 mL/mL kit before use.*
FDA Label Image

Figure G (Glu02 0004 09)

Figure G (Glu02 0004 09)
An instructional line drawing showing two hands preparing a medication injection. The top hand holds a vial upside down, attaching it to a syringe held by the bottom hand. A downward arrow indicates the direction for mixing or drawing liquid into the syringe.*
FDA Label Image

Figure H (Glu02 0004 10)

Figure H (Glu02 0004 10)
Illustration showing a person using a syringe to withdraw medication from a vial. The image focuses on the hands holding the syringe and vial, demonstrating the step of drawing fluid with the needle inserted into the vial.*
FDA Label Image

Figure I (Glu02 0004 11)

Figure I (Glu02 0004 11)
An instructional illustration showing a hand holding a syringe, poised to withdraw or inject liquid from a vial with volume markings at 0.5 mL and 1 mL. An arrow indicates the direction to pull or push the syringe plunger.*
FDA Label Image

Figure J (Glu02 0004 12)

Figure J (Glu02 0004 12)
An anatomical illustration showing front and back views of a human figure with black highlighted areas on the shoulder, abdomen, and thigh, indicating common injection sites for the Glucagon 1 mL/mL kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure K (Glu02 0004 13)

Figure K (Glu02 0004 13)
An instructional illustration showing a person drawing a liquid from a vial into a syringe, likely demonstrating preparation or administration steps for the Glucagon 1 mL/mL kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure L (Glu02 0004 14)

Figure L (Glu02 0004 14)
An instructional illustration showing a hand pressing two fingers against the side of a person's abdomen, likely demonstrating a technique for subcutaneous injection for the Glucagon 1 mL/mL kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Fresenius Kabi Logo (Glu02 0004 15)

FDA Label Image

Vial (Glu02 0004 16)

Vial (Glu02 0004 16)
Label for Glucagon for Injection (Synthetic) 1 mg per vial by Fresenius Kabi USA, LLC. The label indicates the drug is for subcutaneous, intramuscular, or intravenous injection and requires reconstitution with sterile water for injection. Includes lot/expiration placeholder and barcode.*
FDA Label Image

Water (Glu02 0004 17)

Water (Glu02 0004 17)
Label panel for a 1 mL single-dose syringe of Sterile Water for Injection, USP, intended for drug diluent use only. It includes volume marking guides at 0.5 mL and 1 mL. The label shows the manufacturer name Fresenius Kabi and a lot code or identifier 403306A.*
FDA Label Image

Clamshell (Glu02 0004 18)

Clamshell (Glu02 0004 18)
Label for Glucagon Emergency Kit for Low Blood Sugar containing Glucagon for Injection 1 mg per vial. The kit includes one single-dose vial with 1 mg Glucagon for Injection and one prefilled syringe with 1 mL Sterile Water for Injection, USP as diluent. Intended for subcutaneous, intramuscular, or intravenous injection. Labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.